全球宫颈癌自采样装置的评估
综述汇总全球宫颈癌自采样装置数据,聚焦高危HPV及CIN2+检测。常用装置包括Evalyn Brush等,与医生采样相比高危HPV检出无显著差异,可扩大筛查覆盖。
要点
- 自采样装置与医生采样检测高危HPV准确性无显著差异
- 常用装置包括Evalyn Brush、Delphi Screener等
- 自采样有助于扩大资源有限地区筛查覆盖
核心结论
- 自采样装置可有效扩大宫颈癌筛查的全球覆盖,尤其适用于资源有限地区。
- 在低资源和对医生采样有抵触的人群中使用自采样装置可能降低宫颈癌发病率。
研究设计与样本
- 综述,汇总同行评议文献,总结全球宫颈癌自采样装置的患病率、准确性和接受率。
主要发现
- 研究最多的装置包括Evalyn Brush(N=73,986)、Delphi Screener(n=28,020)、FLOQSwab(N=13,638)、Viba-Brush(N=25,565)和Digene Brush(N=12,150)。
- 与医生采样相比,自采样装置样本检测高危HPV的准确性无显著差异。
临床怎么用
- 在资源有限和对医生采样有抵触的人群中,可考虑使用自采样装置检测高危HPV。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nearly 90% of cervical cancer and related fatalities occur in low-income and middle-income countries and low-resourced areas within developed countries. In the 1980s, self-sampling was introduced to reach this vulnerable population and those with behavioral aversion to clinician-based screening. Currently, dozens of self-sampling devices have been studied for cervical cancer screening. Here, we consolidated data from an extensive peer-reviewed literature search to summarize the prevalence, accuracy, and acceptance rates of cervical cancer screening self-sampling devices worldwide. We focused, when available, on samples detecting high-risk human papilloma virus (HPV) in cervical intraepithelial neoplasia grade 2 or more. The most studied and commonly accepted devices described in our review include the Evalyn Brush (N=73,986), Delphi Screener (n=28,020), FLOQSwab (N=13,638), Viba-Brush (N=25,565), and Digene Brush (N=12,150). Compared with clinician-based collection, samples derived from self-sampling devices had no significant difference in accurate detection of high-risk HPV. These self-sampling devices have thus been shown to effectively achieve broader global coverage for cervical cancer screening, particularly for limited-access areas. The use of self-sampling devices in populations with low resources and aversion to clinician-based sampling could have a major influence on detection of high-risk HPV and dysplasia, potentially reducing incidence of cervical cancer worldwide.
引用
- Maybury EK, Ahmad S, McKenzie ND, et al. Worldwide Evaluation of Cervical Cancer Self-Sampling Devices. Obstet Gynecol. 2026. PMID: 41747258. doi:10.1097/AOG.0000000000006179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。